Head, Oncology Clinical Development – ADCs
Key Responsibilities & Accountabilities
- Accountable for end-to-end clinical development of an MOA-focused, multi-tumor asset (registrational trials, regulatory approval, initial market launch) with scientific rigor, speed, and quality.
- Shape and drive clinical development strategy for the asset and disease areas aligned to Oncology portfolio priorities.
- Evaluate and enable novel approaches (e.g., AI/ML, innovative trial designs, external/real-world data) when valuable.
- Provide oversight and visibility across the asset program (progress, risks, dependencies, trade-offs).
- Serve as default senior clinical representative at governance forums (e.g., DRB, PIB) and represent Clinical Development internally/externally (including congress and advisory boards).
- Lead external scientific advisory boards and engagements to inform asset/competitive positioning.
- Act as a connector across Research, Precision Medicine/Companion Diagnostics, Medical Affairs, Commercial, Competitive Intelligence, and Global Product Strategy; drive integrated development and lifecycle planning.
- Foster a culture of empowerment, scientific excellence, inclusion, and collaboration.
Skills & Capabilities
- Senior leadership in early-/late-phase oncology drug development (FTIH through registrational and launch readiness); strong translational-to-clinical strategy translation; portfolio-level accountability; advanced cross-functional/matrix leadership; fluency with innovative development approaches.
Basic Qualifications
- Medical degree (MD/MBBS/MBChB or equivalent); board certification/eligibility/registration in a primary medical specialty.
- Pharmaceutical oncology drug development experience; leadership from FTIH through registrational studies/launch readiness.
- Experience leading ADC or targeted oncology programs; asset/portfolio governance and execution accountability.
- Experience with global health authorities and regulatory submissions; leadership of global cross-functional teams.
Preferred Qualifications
- Board certification/eligibility/registration in medical oncology or hematology/oncology.
- Governance leadership and executive-level decision-making; translational research experience; innovative approaches (advanced analytics/AI-ML/RWE/novel trial design).
Hybrid/Location Note
- Hybrid working; minimum two days/week on-site at UK (Stevenage or London HQ), US (Collegeville/Waltham), or Switzerland (Zug). Role may relocate from Stevenage to Cambridge (proposed early 2029).
#J-18808-Ljbffr
Head, Oncology Clinical Development - ADCs in Stevenage employer: Scorpion Therapeutics
At GSK, we are dedicated to fostering a dynamic and inclusive work environment that empowers our employees to make a real difference in patients' lives. As the Head of RTSM, you will have the opportunity to lead innovative projects in a collaborative culture that values accountability and impact, while benefiting from comprehensive growth opportunities and a robust benefits package. Join us in Upper Providence, Pennsylvania, or Stevenage, UK, where your contributions will directly influence the future of healthcare and help us achieve our ambitious goal of improving the health of 2.5 billion people by the end of the decade.
